West Pharmaceutical Services | WST - Current Liabilities


West Pharmaceutical Services reported $674M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 14.16M Mar/2026
Avanos Medical USD 131.2M 34M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cooper Companies USD 1.8B 209M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Haemonetics USD 282.6M 257.27M Mar/2026
ICU Medical USD 517.9M 19.04M Mar/2026
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 216.87M 22.89M Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Repligen USD 126.21M 9.62M Mar/2026
Rockwell Medical USD 10.95M 259K Jun/2025
Solventum Corp USD 3.35B 210M Mar/2026
STAAR Surgical USD 60.99M 7.51M Mar/2026
Terumo JPY 540.73B 1.03B Mar/2026
Utah Medical Products USD 2.6M 413K Dec/2025
West Pharmaceutical Services USD 674M 19.1M Mar/2026